<DOC>
	<DOCNO>NCT00385125</DOCNO>
	<brief_summary>Phase II study treatment patient relapse primary refractory aggressive B- cell NHL anthracycline chemotherapy pretreatment , receive qualify autologous stem cell transplantation .</brief_summary>
	<brief_title>Treatment Patients With Relapsed Primary Refractory Aggressive B- Cell NHL</brief_title>
	<detailed_description>Phase II study treatment patient relapse primary refractory aggressive B- cell NHL anthracycline chemotherapy pretreatment , receive qualify autologous stem cell transplantation . Aim find response rate duration combination chemotherapy ( bendamustine/rituximab ) patient relapse refractory CD 20 positive B cell NHL .</detailed_description>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Bendamustine Hydrochloride</mesh_term>
	<criteria>Histologically proven high grade BNHL ( CD 20 &gt; = 20 % positive ) Age &gt; = 18 year At least one pretreatment anthracycline polychemotherapy +/ radiatio : first relapse nad contraindication aggressive salvage therapy e.g . high dose therapy autologous stem cell transplantation second relapse ( aggressive salvage therapy ) patient 's refusal aggressive salvage therapy first relapse informed consent untreated patient pretreatment bendamustine primary CNS lymphoma Karnofsky index &lt; 50 ( except cause lymphoma ) HIV positive , hepatitis B C serious concurrent disease noncompensated heart failure ( &gt; =NYHA 3 ) noncompensated hypertension renal insufficiency ( creatinine &gt; 2.0 mg/dl ) , related lymphoma hepatic insufficiency transaminase value great 3fold normal value and/or bilirubin level &gt; 200 µmol/l , relate lymphoma miss compliance respective incapability comply ( e.g.cerebral dysfunction pregnancy hematopoetic insufficiency lymphoma relate ( leucocyte count &lt; = 2500/µl , granulocyte count &lt; = 1000/µl , platelet count &lt; = 80000/µl )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>relapse</keyword>
	<keyword>refractory</keyword>
	<keyword>CD 20 positive</keyword>
</DOC>